• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=8380785).
  

PubMed=3598280
Yamada T., Ueda M., Maeda T., Miyawaki Y., Misaki O., Ueki M., Sugimoto O.
Establishment and characterization of a cell line (OMC-4) originating from a human adenocarcinoma of the uterine cervix.
Nihon Sanka Fujinka Gakkai Zasshi 39:859-860(1987)

PubMed=2531191
Ueda M., Misaki O., Yamada T., Okamoto Y., Goto M., Maeda T., Okamura S., Ueki M., Sugimoto O.
In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines -- comparison between squamous cell carcinoma and adenocarcinoma.
Nihon Sanka Fujinka Gakkai Zasshi 41:1423-1430(1989)

DOI=10.1267/ahc.26.515
Tsuchida K., Okamoto Y., Yamada T., Ueda M., Iijima J., Shiina Y., Hirano H., Rokukawa C., Kasama T., Taki T., Handa S., Ueki M., Adachi K.
Discrimination of metastatic cells from mesothelial cells in effusion cytology by monoclonal antibody AD117m directed against lactotetraosylceramide.
Acta Histochem. Cytochem. 26:515-530(1993)

PubMed=8380785; DOI=10.1006/gyno.1993.1016
Iwasaka T., Oh-uchida M., Matsuo N., Yokoyama M., Fukuda K., Hara K., Fukuyama K., Hori K., Sugimori H.
Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
Gynecol. Oncol. 48:104-109(1993)